Jun 29
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
Synthesized from 10 sources
Sources (10)
Bias Scale:
LeftCenterRight
Seeking AlphaJun 29, 2026, 10:29 PM
Contango settles Lucky Shot milestone payments, gains $9M from Peak Gold JVSeeking AlphaJun 29, 2026, 10:28 PM
AbbVie touts phase 3 results for Epkinly in 2L large B-cell lymphomaSeeking AlphaJun 29, 2026, 10:14 PM
Titan Acquisition's $800M OpenPayd deal moves ahead with SEC filingSeeking AlphaJun 29, 2026, 10:14 PM
Praxis sees encephalopathies asset relutrigine action date extendedSeeking AlphaJun 29, 2026, 10:04 PM
Tilray acquires digital health platform HelloMDSeeking AlphaJun 29, 2026, 9:50 PM
Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturingBloombergJun 29, 2026, 8:13 PM
Susquehanna Says It Lost Millions to Mystery Insider TradersCNBCJun 29, 2026, 6:50 PM
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilitiesReutersJun 29, 2026, 6:39 PM
Apple iPhone 18 Pro supplier list, parts and photos exposed in Tata data leakBloombergJun 29, 2026, 5:59 PM
Super Micro Office Raided as Taiwan Expands Chip Smuggling ProbeComments
No comments yet. Be the first!